Cargando…
Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
Global health, particularly in underserved settings can benefit immensely from well-trained community health workers (CHWs) supporting primary healthcare interventions. They can reduce morbidity and mortality of infectious diseases like malaria. Disease control programs can particularly benefit from...
Autores principales: | Groger, Mirjam, Lutete, Gaston Tona, Assi, Serge-Brice, Bigoga, Jude D., Ntamabyaliro, Nsengi Y., Arbe-Barnes, Sarah, Shin, Jangsik, Adegnika, Ayola A., Ntoumi, Francine, Kremsner, Peter G., Ramharter, Michael, Duparc, Stephan, Borghini-Fuhrer, Isabelle, Mombo-Ngoma, Ghyslain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689247/ https://www.ncbi.nlm.nih.gov/pubmed/37871675 http://dx.doi.org/10.1016/j.ijid.2023.10.016 |
Ejemplares similares
-
Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study
por: Tona Lutete, Gaston, et al.
Publicado: (2021) -
Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial
por: Groger, Mirjam, et al.
Publicado: (2022) -
Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa – A Cross-Sectional Study
por: Kurth, Florian, et al.
Publicado: (2010) -
Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2021) -
Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2022)